Member Info for Bothwell

· US probe revenues up 40% to £1.9m (25% growth in local currency) o Weaker sterling held back US profitability by £0.1m with reported costs and revenues up £0.3m and £0.2m respectively o 28 of 30 target platform accounts at the year-end, target of 30 met in January 2017 o Primary focus now shifted to probe growth in US platform accounts; redeploying resources to support best growth opportunities o Continued strong growth in Q1 2017 together with reduced costs meant that March 2017 was the first month where the contribution from US probe sales covered fixed US sales staff costs · International probe revenues up 25% at £1.7m o 15% increase in volume with an additional net £0.1m revenue growth from currency movements and sales mix · UK probe revenues down 26% at £1.9m. Trend improving: H1 down 36%, H2 down 17% o Down 10% in Q1 2017 with monitor and third party sales meaning that total UK revenues in Q1 2017 are slightly ahead of Q1 2016 · Monitor income down to £0.4m from £0.6m · Second half operating loss, before non-cash costs, of £0.2m (2015: £1.0m). Operating Highlights · New, easier to use, TruVue probes introduced globally · Excellent results presented from largest ever randomised controlled trial of ODM · EU R&D grant awarded for pilot project with new Velocity Pressure Loop displays · Successful field trials completed of additional non-invasive haemodynamic monitoring modality; launch pending

Deltex will start to generate returns from the substantial investments made to date in building its US platform and in new product development. With the sort of high margins they generated this will allow the business to move forward.

A couple of nice trades late yesterday and early today. The future is bright here.

I believe some good news will be rolling out of Deltex very soon. They have had a good year working to conclude new deals.

Would we not have expected the SP to rise higher than this after the huge buys today?

I thought we might have pushed past the £3 marker by now.

Does anyone have an idea what is going on here? Share price has dropped significantly over the years. I would have expected a better return after moving into them USA. I would like to get more information from the board for LTH.

http://www.microcapwired.com/moving-average-watch-for-summit-therapeutics-plc-smmt/51047/

Some nice chunky buys going through after positive results today.

Third Quarter Results out on Thursday.

Not been a great month for the SP. Up at 260 now down at 160. A lot of positive activity in the background so surprised to see a drift in the share price.

Up 7% at the finish in USA tonight. Maybe some more news next week.

I was hoping for another positive RNS in November after Octobers. This is a great stock to be in long term.

Finished up 7% in USA tonight.

Nice to see the sp is up 7% in USA. Hopefully a positive start to next week here.

Any news coming out of Deltex? I would have thought the sp would have been a lot higher due to positive USA roll out.

Where do we think the share price will be before the new year? Hoping another rns comes along soon.

Up 7% in the US as we speak. More good news hopefully not far away.

Some huge buys over the last few days. Confidence in this share and future SP. £3 and £5 are not far away as more good news arrives.

We are well on our way to making it big in the USA. UK will follow again for sure then a buyout of Deltex will be on the cards.